Quality & Patient Safety
As the AHA and its members continue to address maternal mortality, the association today voiced support for the Joint Commission’s recently proposed standards for perinatal safety.
Candida auris is a type of fungus that can cause serious bloodstream and other invasive infections among hospital and post-acute care patients. It often is resistant to multiple antifungal medications. Patients with weakened immune systems, nursing home patients and those who use breathing/feeding…
The Centers for Medicare & Medicaid Services should evaluate state survey agency processes to ensure that all states are meeting federal requirements for investigating complaints and incidents alleging abuse in nursing homes.
U.S. Secretary of Commerce Wilbur Ross Sunday presented the Malcolm Baldrige National Quality Award for performance excellence and innovation to Memorial Hospital and Health Care Center in Jasper, Ind.
Health care is changing rapidly. The rise of consumerism, the digital economy, precision medicine, predictive analytics, artificial intelligence, new high-tech entrants to the health care sector and affordability pressures all serve as catalysts for change. And America’s hospitals and health…
The Centers for Medicare & Medicaid Services and Centers for Disease Control and Prevention this week extended the deadline to comment on their proposed rule updating proficiency testing and referral requirements under the Clinical Laboratory Improvement Amendments from April 5 to June 4.
The Food and Drug Administration today published a proposed rule that would update requirements under the Mammography Quality Standards Act of 1992, which authorized FDA oversight of mammography facilities.
AHA provides input to CMS regarding potential future changes to the Centers for Medicare & Medicaid Services (CMS) hospital overall star ratings system.
In partnership with the AHA and other national health care leaders, the National Quality Forum today launched a task force to identify opportunities to drive and optimize high-value, person-centered care for every patient by 2030.
A federal court has ordered a Texas-based company to stop producing compounded drug products intended to be sterile until the company complies with the Federal Food, Drug, and Cosmetic Act and other requirements.